Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | STAT1 | P42224 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7423974 | 0.81 | TDP1 (0.39) | KMT2AGAACYP1A2CYP2C19SMN1; SMN2 | |
| SCHEMBL27500158 | 0.76 | KDM4E (0.38) | KMT2AGAACYP1A2CYP2C19SMN1; SMN2 | |
| SCHEMBL16783400 | 0.74 | LMNA (0.46) | KMT2AGAACYP1A2CYP2C19SMN1; SMN2 | |
| SCHEMBL5671785 | 0.73 | MAPT (0.41) | GAACYP1A2CYP2C19SMN1; SMN2KDM4E | |
| SCHEMBL1640485 | 0.72 | KMT2A (0.71) | KMT2AGAACYP1A2CYP2C19SMN1; SMN2 | |
| SCHEMBL29655205 | 0.72 | KMT2A (0.71) | KMT2AGAACYP1A2CYP2C19SMN1; SMN2 | |
| SCHEMBL7424707 | 0.72 | ALDH1A1 (0.50) | KMT2AGAASMN1; SMN2LMNAKDM4E | |
| SCHEMBL7427803 | 0.72 | ALDH1A1 (0.53) | KMT2AGAASMN1; SMN2LMNAKDM4E | |
| SCHEMBL3931825 | 0.71 | TDP1 (0.51) | KMT2AGAACYP1A2CYP2C19SMN1; SMN2 | |
| SCHEMBL7426825 | 0.71 | HSD17B10 (0.63) | KMT2AGAACYP2C19SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0820441-B1 | INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS | FUJISAWA PHARMACEUTICAL CO (JP) | 2002-06-26 | — | — | EP | disclosed |
| US-6358992-B1 | Method of inhibiting neoplastic cells with indole derivatives | CELL PATHWAYS, INC. | 2002-03-19 | — | — | US | disclosed |
| US-6069156-A | Indole derivatives as cGMP-PDE inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-05-30 | — | — | US | disclosed |
| EP-0820441-A1 | INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-01-28 | — | — | EP | disclosed |
| WO-1996032379-A1 | INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-10-17 | — | — | WO | disclosed |